TrialThe British journal of ophthalmology2024

Intravitreal bevacizumab improves trabeculectomy survival at 12 months: the bevacizumab in trabeculectomy study-a randomised clinical trial.

John A Landers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.